<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35509185</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1525-6049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Renal failure</Title>
          <ISOAbbreviation>Ren Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.</ArticleTitle>
        <Pagination>
          <StartPage>752</StartPage>
          <EndPage>766</EndPage>
          <MedlinePgn>752-766</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2072337</ELocationID>
        <Abstract>
          <AbstractText>Chronic kidney disease (CKD) has recently become a serious health and social concern. Vascular calcification, a common complication of CKD, is a risk factor that increases the incidence and mortality of cardiovascular events in patients with CKD. However, there are currently no effective therapeutic targets that can facilitate treatment with fewer side effects for vascular calcification in CKD. To identify potential therapeutic targets, we performed label-free quantification (LFQ) analyses of protein samples from rat aortic vascular smooth muscle cells (RASMCs) after high-phosphorus treatment by nano-UPLC-MS/MS. We determined that ubiquitin-specific protease 47 (USP47) may be associated with CKD vascular calcification by regulating the osteogenic transdifferentiation of the vascular smooth muscle cell (VSMC) phenotype, thus suggesting a novel and potentially effective therapeutic target for CKD vascular calcification. USP47 knockdown significantly reduced the expression of Î²-transducin repeat-containing protein (BTRC), serine/threonine-protein kinase akt-1 (AKT1), Klotho, fibroblast growth factor (FGF23), and matrix Gla protein (MGP) in RASMCs after high-phosphorus treatment. Consistent with the results of protein-protein interaction (PPI) analyses, USP47 may be involved in regulating osteogenic transdifferentiation markers, such as runt-related transcription factor 2 (RUNX2), Klotho, FGF23, and MGP through the BTRC/AKT1 pathway upon CKD vascular calcification. These data indicate that USP47 may be associated with vascular calcification in CKD by regulating osteogenic differentiation of VSMCs. USP47 may regulate osteogenic transdifferentiation in VSMCs upon CKD vascular calcification through a process involving the BTRC/AKT1 pathway. This study identified a novel potential therapeutic target for the treatment of vascular calcification in CKD.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Qiong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tang</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Juhua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Jintang First People's Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Haojun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Meidie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Sipei</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pu</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Guisen</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sichuan Clinical Research Center for Kidney Diseases, Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ren Fail</MedlineTA>
        <NlmUniqueID>8701128</NlmUniqueID>
        <ISSNLinking>0886-022X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>27YLU75U4W</RegistryNumber>
          <NameOfSubstance UI="D010758">Phosphorus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.19.12</RegistryNumber>
          <NameOfSubstance UI="D064570">Ubiquitin-Specific Proteases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054338" MajorTopicYN="N">Cell Transdifferentiation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009131" MajorTopicYN="N">Muscle, Smooth, Vascular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032389" MajorTopicYN="N">Myocytes, Smooth Muscle</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010012" MajorTopicYN="N">Osteogenesis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010758" MajorTopicYN="N">Phosphorus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064570" MajorTopicYN="Y">Ubiquitin-Specific Proteases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061205" MajorTopicYN="Y">Vascular Calcification</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic kidney disease</Keyword>
        <Keyword MajorTopicYN="N">Vascular calcification</Keyword>
        <Keyword MajorTopicYN="N">label-free quantification</Keyword>
        <Keyword MajorTopicYN="N">serine/threonine-protein kinase akt-1</Keyword>
        <Keyword MajorTopicYN="N">ubiquitin-specific protease 47</Keyword>
        <Keyword MajorTopicYN="N">vascular smooth muscle cells</Keyword>
        <Keyword MajorTopicYN="N">Î²-transducin repeat-containing protein</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no potential conflicts of interest</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>5</Day>
          <Hour>1</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35509185</ArticleId>
        <ArticleId IdType="pmc">PMC9090392</ArticleId>
        <ArticleId IdType="doi">10.1080/0886022X.2022.2072337</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bikbov B, Purcell CA, Levey AS, et al. . 
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709â733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7049905</ArticleId>
            <ArticleId IdType="pubmed">32061315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Wang F, Wang L, et al. . 
Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;380(9838):214â214.</Citation>
        </Reference>
        <Reference>
          <Citation>Reiss AB, Miyawaki N, Moon J, et al. . 
CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis. 2018;278:49â59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30253289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuasa R, Ohashi Y, Saito A, et al. . 
Prevalence of hypothyroidism in Japanese chronic kidney disease patients. Ren Fail. 2020;42(1):572â579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7946052</ArticleId>
            <ArticleId IdType="pubmed">32567453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hruska KA, Sugatani T, Agapova O, et al. . 
The chronic kidney disease â mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80â86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5502716</ArticleId>
            <ArticleId IdType="pubmed">28119179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong D, Wu S, Pu L, et al. . 
Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol. 2013;14:120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3691830</ArticleId>
            <ArticleId IdType="pubmed">23738982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang XR, Yuan L, Shi R, et al. . 
Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease. Ren Fail. 2021;43(1):1172â1179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8330733</ArticleId>
            <ArticleId IdType="pubmed">34315328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Melamed ML.. 
Vascular calcification in predialysis CKD: common and deadly. Clin J Am Soc Nephrol. 2015;10(4):551â553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4386247</ArticleId>
            <ArticleId IdType="pubmed">25770177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ternacle J, CÃ´tÃ© N, Krapf L, et al. . 
Chronic kidney disease and the pathophysiology of valvular heart Disease â ScienceDirect. Can J Cardiol. 2019;35(9):1195â1207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31472817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vervloet M, Cozzolino M.. 
Vascular calcification in chronic kidney disease: different bricks in the wall?
Kidney Int. 2017;91(4):808â817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27914706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai L, Schurgers L, Shiels P, et al. . 
Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association. Nephrol Dial Transplant. 2020;35(Suppl 2):ii31âii37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7066546</ArticleId>
            <ArticleId IdType="pubmed">32162665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moe SM, Chen NX.. 
Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2008;19(2):213â216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18094365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sepe V, Rampino T, Libetta C.. 
Arterial âinflammagingâ drives vascular calcification in children on dialysis. Kidney Int. 2019;96(2):522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31331477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen NX, O'Neill KD, Moe SM.. 
Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways. Kidney Int. 2018;93(2):343â354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8211355</ArticleId>
            <ArticleId IdType="pubmed">29032812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leopold JA.
Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015;25(4):267â274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4414672</ArticleId>
            <ArticleId IdType="pubmed">25435520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SJ, Lee IK, Jeon JH.. 
Vascular calcification-new insights into its mechanism. IJMS. 2020;21(8):2685.</Citation>
        </Reference>
        <Reference>
          <Citation>Qiu X, Xu Q, Xu T, et al. . 
Metformin alleviates Î²-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy. Exp Ther Med. 2021;21(1):58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7716633</ArticleId>
            <ArticleId IdType="pubmed">33365058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durham AL, Speer MY, Scatena M, et al. . 
Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114(4):590â600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5852633</ArticleId>
            <ArticleId IdType="pubmed">29514202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malhotra R, Mauer AC, Cardenas CLL, et al. . 
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat Genet. 2019;51(11):1580â1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6858575</ArticleId>
            <ArticleId IdType="pubmed">31659325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X, Liu L, Zhang Q, et al. . 
E2F7 transcriptionally inhibits MicroRNA-199b expression to promote USP47, thereby enhancing colon cancer tumor stem cell activity and promoting the occurrence of colon cancer. Front Oncol. 2020;10:565449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7819137</ArticleId>
            <ArticleId IdType="pubmed">33489876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan F, Lou Z, Zhou Z, et al. . 
Long non-coding RNA KCNQ1OT1 promotes nasopharyngeal carcinoma cell cisplatin resistance via the miR-454/USP47 axis. Int J Mol Med. 2021;47(4):54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7895519</ArticleId>
            <ArticleId IdType="pubmed">33576460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hou X, Xia J, Feng Y, et al. . 
USP47-mediated deubiquitination and stabilization of TCEA3 attenuates pyroptosis and apoptosis of colorectal cancer cells induced by chemotherapeutic doxorubicin. Front Pharmacol. 2021;12:713322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8495243</ArticleId>
            <ArticleId IdType="pubmed">34630087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Setz C, Friedrich M, Rauch F, et al. . 
Inhibitors of deubiquitinating enzymes block HIV-1 replication and augment the presentation of gag-derived MHC-I epitopes. Viruses. 2017;9(8):222.</Citation>
        </Reference>
        <Reference>
          <Citation>Tran AT, Rahim MN, Ranadheera C, et al. . 
Knockdown of specific host factors protects against influenza virus-induced cell death. Cell Death Dis. 2013;4(8):e769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3763457</ArticleId>
            <ArticleId IdType="pubmed">23949218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashton-Beaucage D, Lemieux C, Udell CM, et al. . 
The deubiquitinase USP47 stabilizes MAPK by counteracting the function of the N-end rule ligase POE/UBR4 in Drosophila. PLoS Biol. 2016;14(8):e1002539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4994957</ArticleId>
            <ArticleId IdType="pubmed">27552662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi J, Liu Y, Xu X, et al. . 
Deubiquitinase USP47/UBP64E regulates Î²-Catenin ubiquitination and degradation and plays a positive role in wnt signaling. Mol Cell Biol. 2015;35(19):3301â3311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4561727</ArticleId>
            <ArticleId IdType="pubmed">26169834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Tang Y, Wang Y, et al. . 
Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification. Ren Fail. 2019;41(1):220â228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6461080</ArticleId>
            <ArticleId IdType="pubmed">30973285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Li Y, Ding H, et al. . 
Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway. Ren Fail. 2016;38(7):1099â1106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27300444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garland JS, Holden RM, Groome PA, et al. . 
Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis. 2008;52(5):849â858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18562059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parsons JL, Dianova II, Khoronenkova SV, et al. . 
USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase Î². Mol Cell. 2011;41(5):609â615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21362556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sako-Kubota K, Tanaka N, Nagae S, et al. . 
Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions. Mol Biol Cell. 2014;25(24):3851â3860.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4244195</ArticleId>
            <ArticleId IdType="pubmed">25253721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PalazÃ³n-Riquelme P, Worboys JD, Green J, et al. . 
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep. 2018;19(10):e44766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6172458</ArticleId>
            <ArticleId IdType="pubmed">30206189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ka HI, Lee S, Han S, et al. . 
Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA. Cell Death Discov. 2020;6:34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7198525</ArticleId>
            <ArticleId IdType="pubmed">32377397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang TL, Lin SW, Wu SL, et al. . 
Regulation of ubiquitin and 26S proteasome mediated by phenolic compounds during oxidative stress. J Nutr Biochem. 2013;24(11):1970â1981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24075904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen B, Zhao Y, Han D, et al. . 
Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression. J Mol Cell Cardiol. 2019;135:10â21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31356809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang M, Zheng L, Xu H, et al. . 
Oxidative stress contributes to vascular calcification in patients with chronic kidney disease. J Mol Cell Cardiol. 2020;138:256â268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31866376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao S, Guo Y, Diao Z, et al. . 
Genome-wide identification of lncRNAs and mRNAs differentially expressed in human vascular smooth muscle cells stimulated by high phosphorus. Ren Fail. 2020;42(1):437â446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7269060</ArticleId>
            <ArticleId IdType="pubmed">32401115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatakeyama S, Kitagawa M, Nakayama K, et al. . 
Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A. 1999;96(7):3859â3863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC22385</ArticleId>
            <ArticleId IdType="pubmed">10097128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CW, Xia W, Lim SO, et al. . 
AKT1 inhibits epithelial-to-mesenchymal transition in breast cancer through phosphorylation-dependent Twist1 degradation. Cancer Res. 2016;76(6):1451â1462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4794388</ArticleId>
            <ArticleId IdType="pubmed">26759241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peschiaroli A, Skaar JR, Pagano M, et al. . 
The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival. Oncogene. 2010;29(9):1384â1393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3869786</ArticleId>
            <ArticleId IdType="pubmed">19966869</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
